(function(){
			var content_array=["<p><b><i><u>参考文献：<\/u><\/i><\/b><\/p> \n<p>[1].晓马.3000万糖尿病患者，要当心100多种并发症[J].中老年保健,2008(11):48.<\/p> \n<p>[2].&nbsp;Mosenzon O, Alguwaihes A, Arenas Leon J.L., <i>et al<\/i>. CAPTURE: a cross-sectional study of the contemporary (2019) prevalence of cardiovascular disease in adults with type 2 diabetes across 13 countries. Abstract 158. Presented at the 56th Annual Meeting of the European Association of the Study of Diabetes, Macrovascular complications and beyond, <span class=\"xn-chron\">10:15 CDT<\/span> on <span class=\"xn-chron\">24 September 2020<\/span>.<\/p> \n<p>[3]. Vencio S, Alguwaihes A, Arenas Leon J.L., <i>et al<\/i>. Contemporary use of diabetes medications with a cardiovascular indication in adults with type 2 diabetes: a secondary analysis of the multinational CAPTURE study. Abstract 945. Presented at the 56th Annual Meeting of the European Association of the Study of Diabetes, Cardiovascular complications in humans through and through, <span class=\"xn-chron\">13:15 CDT<\/span> on <span class=\"xn-chron\">24 September 2020<\/span>.<\/p> \n<p>[4]. National Institute of Health (NIH). Atherosclerosis. Available at: <a href=\"https:\/\/t.prnasia.com\/t\/2dFrNOim\" rel=\"nofollow\">https:\/\/www.nhlbi.nih.gov\/health-topics\/atherosclerosis<\/a> Last accessed: <span class=\"xn-chron\">July 2020<\/span>.<\/p> \n<p>[5]. Buse JB, Wexler DJ, Tsapas A, <i>et al<\/i>. 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2019.<\/p> \n<p>[6]. Buse JB, Wexler DJ, Tsapas A, <i>et al<\/i>. 2019 update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2019.<\/p> \n<p>[7]. Cosentino F, Grant PJ, Aboyans V, <i>et al<\/i>. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD), European Heart Journal. DOI: <a target=\"_blank\" href=\"https:\/\/t.prnasia.com\/t\/0V9FkLtZ\" rel=\"nofollow\">https:\/\/doi.org\/10.1093\/eurheartj\/ehz486<\/a>.<\/p> \n<p>[8]. Barquera S, Pedroza-Tobias A, Medina C, et al. Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease. Arch Med Res. 2015; 46:328–338.<\/p> \n<p>[9]. Li Yongze, et al., . Prevalence of diabetes recorded in mainland <span class=\"xn-location\">China<\/span> using 2018 diagnostic criteria from the American Diabetes Association: national cross pal study. BMJ 2020;369:m997 DOI: 10.1136\/bmj.m997<\/p> \n<p>&nbsp;<\/p>"];
			$("#dvExtra").html(content_array[0]);})();